GSK Seeks To Prevent Pfizer From Selling Its Rival RSV Vaccine In the US

Claiming Pfizer’s Abrysvo infringes four of its patents, GSK asks court to permanently enjoin Pfizer from making or selling the vaccine in the US but would exempt the pending maternal indication.